GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Policy Acquisition Expense

Noile-Immune Biotech (TSE:4893) Policy Acquisition Expense


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Noile-Immune Biotech (TSE:4893) Business Description

Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.